Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:51 PM
Ignite Modification Date:
2025-12-24 @ 2:51 PM
NCT ID:
NCT00002059
Eligibility Criteria:
Exclusion Criteria
Co-existing Condition:
Patients with the following are excluded:
* Opportunistic infections or Kaposi's sarcoma.
* Critical illness.
* History of gout, urolithiasis, nephrolithiasis, renal dysfunction, and severe gastric ulcer.
Concurrent Medication:
Excluded:
* Steroids.
* Cytotoxic immunosuppressive agents.
Concurrent Treatment:
Excluded:
* Radiotherapy.
The following are excluded:
* Opportunistic infections or Kaposi's sarcoma.
* Critically ill patients.
* Patients receiving steroids, cytotoxic immunosuppressive agents, and/or radiotherapy.
* Patients who have received any other immunotherapy.
* Patients with a history of gout, urolithiasis, nephrolithiasis, renal dysfunction, and severe gastric ulcer.
Prior Medication:
Excluded:
* Any other immunotherapy.
Patients who fall into the group which is at risk of developing cutaneous sarcoma and/or opportunistic diseases but at present have no signs or symptoms of these diseases.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT00002059
Study Brief:
Protocol Section:
NCT00002059